首页> 外文期刊>Clinical and vaccine immunology: CVI >Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages
【24h】

Serum Concentrations of Antibodies against Outer Membrane Protein P6, Protein D, and T- and B-Cell Combined Antigenic Epitopes of Nontypeable Haemophilus influenzae in Children and Adults of Different Ages

机译:针对不同年龄的儿童和成年人的不可分型流感嗜血杆菌外膜蛋白P6,蛋白D,T细胞和B细胞结合抗原表位的抗体血清浓度

获取原文
获取外文期刊封面目录资料

摘要

Nontypeable Haemophilus influenzae (NTHi) is one of the most common etiologies of acute otitis media, rhinosinusitis, and pneumonia. Outer membrane proteins (OMPs) are the main focus in new vaccine development against NTHi, as the H. influenzae type b (Hib) vaccine does not cover noncapsulated NTHi. The OMPs P6 and protein D are the most promising candidate antigens for an NTHi vaccine, and low antibody levels against them in serum may be correlated with infection caused by NTHi. In the current study, we measured the antibody titers against P6, protein D, and their T- and B-cell combined peptide epitopes in healthy individuals of different ages. We found that children <1 month old had the lowest antibody levels against NTHi P6, protein D, and their T- and B-cell combined antigenic epitopes. Antibody titers increased at ages 1 to 6 months, peaked at 7 months to 3 years, and remained high at 4 to 6 years. The antibody titers started to decrease after 6 years and were the lowest in the 21- to 30-year group. The geometric mean titers (GMTs) of T- and B-cell combined antigenic epitopes in P6 and protein D were positively correlated with those of the protein antigens. Among 12 peptides tested, P6-61, P6-123, and protein D-167 epitopes were better recognized than others in human serum. These findings might contribute to the development of an effective serotype-independent vaccine for H. influenzae.
机译:非分型流感嗜血杆菌(NTHi)是急性中耳炎,鼻-鼻窦炎和肺炎的最常见病因之一。外膜蛋白(OMP)是针对NTHi的新疫苗开发的主要重点,因为b型流感嗜血杆菌(Hib)疫苗不包括未封装的NTHi。 OMPs P6和D蛋白是NTHi疫苗最有希望的候选抗原,血清中针对它们的低抗体水平可能与NTHi引起的感染有关。在当前研究中,我们测量了不同年龄健康个体中针对P6,蛋白D及其T细胞和B细胞结合的肽表位的抗体效价。我们发现,<1个月大的儿童对NTHi P6,蛋白D及其T细胞和B细胞结合抗原表位的抗体水平最低。抗体效价在1至6个月大时增加,在7个月至3年时达到峰值,并在4至6年时保持高水平。抗体效价在6年后开始下降,在21至30年组中最低。 P6和D蛋白中T细胞和B细胞结合抗原表位的几何平均滴度(GMT)与蛋白抗原的几何平均滴度呈正相关。在测试的12种肽中,P6-61,P6-123和蛋白质D-167表位在人血清中比其他肽更好地被识别。这些发现可能有助于开发一种有效的不依赖血清型的流感嗜血杆菌疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号